Cantex Pharmaceuticals, Inc. - Net Worth and Insider Trading
Cantex Pharmaceuticals, Inc. Net Worth
The estimated net worth of Cantex Pharmaceuticals, Inc. is at least $12 Million dollars as of 2024-12-28. Cantex Pharmaceuticals, Inc. is the 10% Owner of Chimerix Inc and owns about 3,500,000 shares of Chimerix Inc (CMRX) stock worth over $12 Million. Details can be seen in Cantex Pharmaceuticals, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cantex Pharmaceuticals, Inc. has not made any transactions after 2021-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cantex Pharmaceuticals, Inc. owns 1 companies in total, including Chimerix Inc (CMRX) .
Click here to see the complete history of Cantex Pharmaceuticals, Inc.’s form 4 insider trades.
Insider Ownership Summary of Cantex Pharmaceuticals, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2021-09-14 | 10 percent owner |
Cantex Pharmaceuticals, Inc. Latest Holdings Summary
Cantex Pharmaceuticals, Inc. currently owns a total of 1 stock. Cantex Pharmaceuticals, Inc. owns 3,500,000 shares of Chimerix Inc (CMRX) as of September 14, 2021, with a value of $12 Million.
Latest Holdings of Cantex Pharmaceuticals, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMRX | Chimerix Inc | 2021-09-14 | 3,500,000 | 3.46 | 12,110,000 |
Holding Weightings of Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Cantex Pharmaceuticals, Inc. has made a total of 1 transactions in Chimerix Inc (CMRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Chimerix Inc is the sale of 6,500,000 shares on September 14, 2021, which brought Cantex Pharmaceuticals, Inc. around $37 Million.
Insider Trading History of Cantex Pharmaceuticals, Inc.
- 1
Cantex Pharmaceuticals, Inc. Trading Performance
Cantex Pharmaceuticals, Inc. Ownership Network
Cantex Pharmaceuticals, Inc. Owned Company Details
What does Chimerix Inc do?
Who are the key executives at Chimerix Inc?
Cantex Pharmaceuticals, Inc. is the 10 percent owner of Chimerix Inc. Other key executives at Chimerix Inc include Chief Business Officer Michael T. Andriole , Principal Accounting Officer David Jakeman , and director & Chief Executive Officer Michael A. Sherman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, Cantex Pharmaceuticals, Inc. made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 40,000 shares made by Fred A Middleton , a net sale of 6,270 shares made by David Jakeman , and a net sale of 3,029 shares made by Michael T. Andriole .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,239 shares of Chimerix Inc (CMRX) were sold and 40,000 shares were bought by its insiders, resulting in a net purchase of 28,761 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
Cantex Pharmaceuticals, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Cantex Pharmaceuticals, Inc.. You might contact Cantex Pharmaceuticals, Inc. via mailing address: 1792 Bell Tower Lane, Suite 222, Weston Fl 33326.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
